ReviewThe Lancet. Respiratory medicine2017

Obesity-related, metabolic asthma: a new role for glucagon-like peptide 1 agonists.

Dan-Vinh Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.